Retinal Ischemia
9
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Ambulatory Stroke Unit Treatment for Elderly Patients
Visual Involvement in Giant Cell Arteritis
Fundus Optical coheRence Tomography Angiography Evaluation for Small-vessel Health in Cerebral Small Vessel Disease
Spectral-domain Optical Coherence Tomography Findings in Retinal Vessel Occlusion
Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus
Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
Oxygen Therapy for Retinal Ischemia
Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease